Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-pe... netrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California. Read More

Alumis Employee Directory

Q: Who are Alumis key employees?

Some of Alumis key employees are Jorn Drappa , Sanam Pangali

Alumis corporate office is located in 280 E Grand Ave, South San Francisco, California, 94080, United States and has 201-500 employees.

Highly Engaged Employees

alumis inc

alumis

Employees by Department

Departments

Number of employees

Medical & Health

Operations

Engineering & Technical

Finance

C-Suite

Legal

Information Technology

Key Employees of Alumis

Jorn Drappa
Chief Medical Officer
PhoneEmail
SP
Sanam Pangali
Chief Legal Officer
PhoneEmail
PhoneEmail
PhoneEmail
PhoneEmail
PhoneEmail

Alumis Global Presence

Location	People at location
North America	51-200
Europe	1-10

Index of contact profiles from Alumis

Hundreds of professionals searching for Alumis have connected with key decision-makers. Join them?

Contact Name

Contact Info

Job Title

HQ Location

WP
Wendy Piloto
Email Direct
Senior Medical Science Liaison
United States , California , South San Francisco

KK
Kristine Kucera
Email Direct
Medical Science Liaison
United States , California , South San Francisco

DW
Denise Winn
Email Direct
Controller
United States , California , South San Francisco

BB
Beverly Brown
Email Direct
Executive Director
United States , California , South San Francisco

PN
Philip Nunn
Email Direct
Senior VP, Preclinical Development Alumis Inc
United States , California , South San Francisco

SP
Sanam Pangali
Email Direct
Chief Legal Officer
United States , California , South San Francisco

AT
Alexander Tseng
Email Direct
Scientist - Data Scientist
United States , California , South San Francisco

RQ
Roger Quintor
Email Direct
Director, Infrastructure & Operations
United States , California , South San Francisco

KP
Karen Pellett
Email Direct
Vice President & Head of Program & Portfolio Management
United States , California , South San Francisco

MK
Mark Kresnak
Email Direct
Senior VP, Legal
United States , California , South San Francisco

JX
Jingrong Xu
Email Direct
Senior Director, Drug Product Development
United States , California , South San Francisco

YC
Yan Chang
Email Direct
Director
United States , California , South San Francisco

Jorn Drappa
Email Direct
Chief Medical Officer
United States , California , South San Francisco

AV
Alina Villanueva
Email Direct
Implementation Senior Manager, Systems
United States , California , South San Francisco

MB
Michael Bradshaw
Email Direct
Vice President of Discovery Biology and Biochemistry
United States , California , South San Francisco

XQ
Xiaoping Qi
Email Direct
Senior Director, Regulatory Affairs
United States , California , South San Francisco

JL
Jacob LaStant
Email Direct
Associate Director, Vivarium Operations & Dmpk
United States , California , South San Francisco

TF
Tania Froman
Email Direct
Global Director, Regulatory Affairs
United States , California , South San Francisco

EM
Elisa Muscianisi
Email Direct
Vice President, Clinical Development
United States , California , South San Francisco

KL
Kenneth Lawson
Email Direct
Senior Director, Analytical Development
United States , California , South San Francisco

TT
Tiffany Tjon
Email Direct
Associate Director, Gmp Quality
United States , California , South San Francisco

AS
Antonia Simien
Email Direct
Director, Program & Portfolio Management
United States , California , South San Francisco

JW
Jennifer Willetts
Email Direct
Executive Director, National, Field Medical
United States , California , South San Francisco

RH
Roy Hardiman
Email Direct
Business Chief & Strategy Officer
United States , California , South San Francisco

KC
Kaela Crowley
Email Direct
Accounting Senior Manager, Research & Development
United States , California , South San Francisco

12 3 45

Former Employees at Alumis

Explore people who held key positions, contributed to Alumis's success, and advanced their careers.

Rebecca McKenna

Operations Project Man... at Kura Oncology

Worked as Project Manager, Medical Affairs (Contract)

at Alumis (2024-2025)

Direct

Regan Burns

Executive Director, Cl... at Jasper Therapeutics

Worked as Director, Clinical Operations

at Alumis (2024-2024)

Direct

Angela Whitehill

Affairs Operations & S... at Nkarta

Worked as Affairs Excellence & Operations Senior Directo...

at Alumis

Direct

Mask Content

Global Medical Strateg... at Otsuka America Pharmac...

Worked as Vice President, Medical Affairs

at Alumis (2024-2026)

Direct

Mask Content

Director, Clinical Dat... at 4D Molecular Therapeut...

Worked as Director, Data Management

at Alumis

Direct

Mask Content

Associate Director at Vir Biotechnology

Worked as Associate Director, Clinical Data Management

at Alumis (2022-2023)

Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in California, United States

KLA

10K+ Employees

Intuitive Surgical

10K+ Employees

ICU Medical

10K+ Employees

Marvell

5K - 10K Employees

Gallo

5K - 10K Employees

Kwikset

5K - 10K Employees

Frequently Asked Questions Regarding Alumis Employees

How many employees does Alumis have?

Alumis has 201-500 employees

Who are Alumis key employees?

Some of Alumis key employees are Jorn Drappa, Sanam Pangali

Where is Alumis located?

Alumis’s headquarters are located at 280 E Grand Ave, South San Francisco, California, 94080, United States

How do I contact Alumis?

Alumis Contact Info: Phone number: (650) 231-6625 Website: www.alumis.com

What does Alumis do?

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-pe... Read More

Is Alumis a public company?

Yes, Alumis is a public company and is traded under the symbol ALMS

See more information about Alumis Employees